U.S. market Closed. Opens in 1 day 4 hours

TFFP | TFF Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue733.87KN/AN/AN/AN/A
Cost of Revenue502.48K388.22K111.45KN/AN/A
Gross Profit231.39K-388.22K-111.45KN/AN/A
Operating Expenses22.63M31.80M31.79M18.69M11.99M
Selling, General & Admin10.57M13.80M10.57M8.01M3.17M
Research & Development11.56M18.50M21.30M10.68M8.82M
Other Operating ExpensesN/A-495.81K-88.16KN/AN/A
Operating Income-21.89M-31.80M-31.79M-18.69M-11.99M
Other Expenses / Income651.43K26.73K747.95K126.42K117.33K
Before Tax Income-21.24M-31.77M-31.04M-18.57M-11.87M
Income Tax ExpensesN/A-26.00-51.23K-126.42K-117.33K
Net Income-21.24M-31.77M-30.99M-18.44M-11.75M
Interest ExpensesN/AN/AN/AN/AN/A
Basic Shares Outstanding1.79M1.20M992.84K817.01K276.20K
Diluted Shares Outstanding1.79M1.20M992.84K817.01K276.20K
EBITDA-20.74M-31.41M-30.93M-18.69M-11.99M
EBITDA Margin-2,826.21%0.00%0.00%0.00%0.00%
EBIT-21.24M-31.77M-31.04M-18.57M-11.87M
EBIT Margin-2,894.68%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙